Skip to main content

Upstream Bio, Inc.

UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002022626

In the last 90 days, Upstream Bio, Inc. insiders filed 0 open-market purchases and 5 sales; 148 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.

Holders of 5% or more of UPB

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Upstream Bio, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of UPB
HolderLatest formStakeChangeFirst filedLatest filingFiling
Norges Bank13G/A7.73%4.21M shares+2.43 ppfrom 5.30%Oct 24, 20252 filingsAug 12, 2026SEC
FMR LLC13G/A6.90%3.79M shares−7.90 ppfrom 14.80%Nov 7, 20244 filingsNov 6, 2026SEC
BlackRock, Inc.13G5.20%2.81M sharesNewJul 30, 20261 filingJul 30, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

17 Schedule 13D and 13G filings on Upstream Bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on UPB
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 6, 20269:45 AM ETFMR LLCand 1 other13G/A6.90%3.79M shares−7.90 ppfrom 14.80%Oct 30, 2026SEC
Oct 29, 20264:13 PM ETDecheng Capital Global Life Sciences Fund IV, L.P.and 2 others13G/A4.90%2.72M shares−0.10 ppfrom 5.00%Below 5%Sep 30, 2026SEC
Aug 12, 20266:36 AM ETNorges Bank13G/A7.73%4.21M shares+2.43 ppfrom 5.30%Jun 30, 2026SEC
Jul 30, 202611:18 AM ETBlackRock, Inc.13G5.20%2.81M sharesNewJun 30, 2026SEC
May 15, 20264:15 PM ETDecheng Capital Global Life Sciences Fund IV, L.P.and 4 others13G/A5.00%2.72M shares−1.10 ppfrom 6.10%Mar 31, 2026SEC
Nov 14, 20254:27 PM ETTCG Crossover GP I, LLCand 2 others13G/A3.90%2.12M shares−1.30 ppfrom 5.20%Below 5%Sep 30, 2025SEC
Nov 14, 20254:05 PM ETHBM Healthcare Investments (Cayman) Ltd.13G/A4.10%2.20M shares−1.00 ppfrom 5.10%Below 5%Sep 30, 2025SEC
Oct 24, 20254:48 PM ETNorges Bank13G5.30%2.88M sharesNewSep 30, 2025SEC
Aug 6, 202512:19 PM ETFMR LLCand 1 other13G/A14.80%7.94M shares+1.40 ppfrom 13.40%Jun 30, 2025SEC
Feb 14, 20255:38 PM ETDecheng Capital Global Life Sciences Fund IV, L.P.and 4 others13G6.10%3.29M sharesNewDec 31, 2024SEC
Feb 14, 20254:23 PM ETTCG Crossover GP I, LLCand 2 others13G5.20%2.80M sharesNewDec 31, 2024SEC
Feb 13, 20254:16 PM ETHBM Healthcare Investments (Cayman) Ltd.13G5.10%2.72M sharesNewDec 31, 2024SEC
Feb 12, 20259:34 AM ETFMR LLCand 1 other13G/A13.40%7.18M shares–Dec 31, 2024SEC
Nov 7, 2024FMR LLC13GOld format–New–SEC
Oct 22, 2024AI Upstream LLC13DOld format–New–SEC
Oct 18, 2024BCLS Fund III Investments, LP13GOld format–New–SEC
Oct 17, 2024OrbiMed Advisors LLC13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Upstream Bio, Inc. shares.

No Form 144 notices for Upstream Bio, Inc. are on file.